drugset / Trial / NCT06055712

Antibiotic Prophylaxis in Pediatric Open Fractures

NCT06055712

Phase 4 Enrolling by invitation 800 enrolled St. Louis University
RandomizedParallel-groupOpen-labelPrevention

Summary

This research will involve a prospective study on infection rates after grade 1 or 2 open fractures in the skeletally immature pediatric population. There will be 3 arms: one dose intravenous cefazolin, 24 hours intravenous cefazolin, and 24 hours intravenous cefazolin plus 5 days of oral cephalexin.

Timeline

Start
2023-09-11
Primary completion
2033-09
Completion
2034-01

Drugs

EvaluationDrugModalityDoseRoute
Comparator CEPHALEXIN ANHYDROUS Small molecule Oral
Comparator Cefazolin Small molecule Intravenous

Indications